Your browser doesn't support javascript.
loading
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.
Rao, Srinivasa; Verrill, Clare; Cerundolo, Lucia; Alham, Nasullah Khalid; Kaya, Zeynep; O'Hanlon, Miriam; Hayes, Alicia; Lambert, Adam; James, Martha; Tullis, Iain D C; Niederer, Jane; Lovell, Shelagh; Omer, Altan; Lopez, Francisco; Leslie, Tom; Buffa, Francesca; Bryant, Richard J; Lamb, Alastair D; Vojnovic, Boris; Wedge, David C; Mills, Ian G; Woodcock, Dan J; Tomlinson, Ian; Hamdy, Freddie C.
Affiliation
  • Rao S; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. Srinivasa.rao@nds.ox.ac.uk.
  • Verrill C; Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK. Srinivasa.rao@nds.ox.ac.uk.
  • Cerundolo L; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Alham NK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Kaya Z; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • O'Hanlon M; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Hayes A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Lambert A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • James M; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Tullis IDC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Niederer J; Department of Oncology, University of Oxford, Oxford, UK.
  • Lovell S; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Omer A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Lopez F; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Leslie T; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Buffa F; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Bryant RJ; Department of Oncology, University of Oxford, Oxford, UK.
  • Lamb AD; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Vojnovic B; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Wedge DC; Department of Oncology, University of Oxford, Oxford, UK.
  • Mills IG; Manchester Cancer Research Centre, University of Manchester, Manchester, UK.
  • Woodcock DJ; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Tomlinson I; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Hamdy FC; Department of Oncology, University of Oxford, Oxford, UK.
Genome Med ; 16(1): 35, 2024 02 19.
Article in En | MEDLINE | ID: mdl-38374116
ABSTRACT

BACKGROUND:

Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.

METHODS:

We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.

RESULTS:

In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.

CONCLUSIONS:

Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Language: En Journal: Genome Med Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Language: En Journal: Genome Med Year: 2024 Document type: Article